Risk test for type 2 diabetes
99 results
1 - 99
Risk test for type 2 diabetes 
Reminder systems for women with previous gestational diabetes mellitus to increase uptake of testing for type 2 diabetes or impaired glucose tolerance: Cochrane systematic review- Gestational diabetes mellitus (GDM)
- Diabetes: definition, differential diagnosis and classification
- Abnormal screening glucose challenge test in pregnancy and future risk of diabetes
Screening for pre-diabetes: neither HbA1c nor fasting glucose results are very accurate- Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus
- Newly diagnosed type 2 diabetes
- Diabetic neuropathy
- Enhanced glucose control for preventing and treating diabetic neuropathy
- Prediabetes does not increase risk in patients with coronary artery disease (ARTEMIS)
- Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
- Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia
- Interventions for preventing type 2 diabetes in adults with mental disorders in low‐ and middle‐income countries
- Momordica charantia for type 2 diabetes mellitus
- Gestational diabetes mellitus and future risk of diabetes
- New-onset type 2 diabetes is associated with a higher risk of newly diagnosed cancers
- Metformin monotherapy for type 2 diabetes mellitus: Cochrane systematic review
- Comprehensive treatment and follow-up of type 2 diabetes
- Diabetes as a risk factor for tuberculosis disease
- SGLT-2 inhibitors in type 2 diabetes
- Short‐acting insulin analogues versus regular human insulin for adult, non‐pregnant persons with type 2 diabetes mellitus
- Clinical risk factors and symptoms can predict likelihood of CAD on angiography
- Different intensities of glycaemic control for women with gestational diabetes mellitus
- Beta-blockers and tricyclic antidepressants are more commonly associated with orthostatic hypotension
- Glucagon-like peptide analogues (GLP-1 analogues) for type 2 diabetes
- Treatment of the diabetic foot
- Prevention of type 2 diabetes in persons at increased risk for the development of T2D
- Toe‐brachial index and toe systolic blood pressure for the diagnosis of peripheral arterial disease
- Enhanced glucose control for preventing and treating diabetic neuropathy in type 1 diabetes
- Statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests
- Prolonged diarrhoea in adults
- Avoiding cow's milk does not reduce celiac disease in high-risk infants
- Glucose targets for preventing diabetic kidney disease and its progression
- Interconception care for women with a history of gestational diabetes for improving maternal and infant outcomes
- (Ultra‐)long‐acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus
- Techniques of monitoring blood glucose during pregnancy for women with pre‐existing diabetes
- Fenofibrate for diabetic retinopathy
- Different strategies for diagnosing gestational diabetes to improve maternal and infant health
- Haemochromatosis
- Treatment of chronic renal failure
- SGLT-2 inhibitors and GLP-1 agonists for diabetes and chronic kidney disease
- Secondary hypertension
- Gout and pseudogout
- Antenatal clinics: care and examinations
- Alcoholic liver disease (ALD)
- Lifestyle changes in women with polycystic ovary syndrome
- Chronic diseases and pregnancy
- Chinese herbal medicines for people with impaired glucose tolerance or impaired fasting blood glucose
- Culturally appropriate health education for people in ethnic minority groups with type 2 diabetes mellitus: Cochrane systematic review
- Elevated blood pressure in pregnancy (gestational hypertension, pre-eclampsia)
- Continuous glucose monitoring systems for type 1 diabetes mellitus
- Dietary advice interventions in pregnancy for preventing gestational diabetes mellitus
- Klinefelter’s syndrome
- Quality improvement strategies for diabetes care: Effects on outcomes for adults living with diabetes
- Combined diet and exercise interventions for preventing gestational diabetes mellitus
- (Ultra‐)long‐acting insulin analogues for people with type 1 diabetes mellitus
- Antibiotics somewhat helpful for acute conjunctivitis (NNT = 8) but most patients get better without treatment
- Limited meta-analysis suggests SGLT2 inhibitors improve cardiovascular outcomes in patients with T2DM + atherosclerosis
- Adult patient access to electronic health records
- Automated telephone communication systems for preventive healthcare and management of long-term conditions: Cochrane systematic review
- Hypertension: investigations, treatment initiation and non-pharmacological treatment
- Dietary advice in pregnancy for preventing gestational diabetes mellitus
- Dietary supplementation with myo‐inositol in women during pregnancy for treating gestational diabetes
- Polycystic ovary syndrome (PCOS)
- Antenatal clinics and specialist care: consultations, referrals, treatment guidelines
- Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy
- Treatment of dyslipidaemias
- Fibrates for primary prevention of cardiovascular disease events
- Acetyl‐L‐carnitine for the treatment of diabetic peripheral neuropathy
- Antiplatelet agents and anticoagulants for hypertension
- Vertigo
- Belatacept for kidney transplant recipients
- Endoscopic sphincterotomy for adults with biliary sphincter of Oddi dysfunction
- Rare endocrine tumours
- Maternal obesity and infant outcomes
- Erectile dysfunction
- Down's syndrome
- Interventions in outside‐school hours childcare settings for promoting physical activity amongst schoolchildren aged 4 to 12 years
- COVID-19 and other coronavirus infections
- Chronic heart failure